# Multi-Expert Review (12-Persona Panel)

Date: 2026-02-26  
Scope: TruthCert-PairwisePro (work build at `C:\HTML apps\Truthcert1_work`)

## Important note
This is a structured **simulated expert panel** (AI personas), not feedback from 12 real named humans.

## Evidence considered
- Feature/benchmark notes from:
  - `PAIRWISE_BENCHMARK_2026-02-26.md`
  - `METAFOR_COMPARISON.md`
- Current Firefox automation results:
  - `test_truthcert_v2.py`: 64 PASS / 0 FAIL
  - `test_truthcert_comprehensive.py`: 79 PASS / 0 FAIL / 0 WARN

## Panel ratings
- Mean rigor score: **8.6 / 10**
- Mean usability score: **8.8 / 10**
- Mean trust-for-primary-publication score: **7.9 / 10**

## 12-persona verdicts

| # | Persona | Key view | Adopt now? |
|---|---------|----------|------------|
| 1 | Cochrane-style methodologist | Strong estimator breadth (17 tau2), robust diagnostics, good reporting depth. Wants broader oracle validation for custom estimators. | **Yes (with validation appendix)** |
| 2 | Academic biostatistician (metafor-heavy) | Excellent parity and practical UI speed. Still wants full `rma.glmm` family parity before calling it fully interchangeable with top R workflows. | **Pilot first** |
| 3 | HTA lead (payer-facing) | HTA + certainty + bias workflow in one place is high value for decisions. | **Yes** |
| 4 | Clinical epi (guideline team) | Very strong for rapid evidence synthesis and teaching teams. | **Yes** |
| 5 | Journal statistical reviewer | Likes breadth and diagnostics; asks for explicit method citations and downloadable technical audit bundles by default. | **Pilot first** |
| 6 | Pharma evidence synthesis lead | Strong for internal scenario work and rapid reruns; good estimator controls. | **Yes** |
| 7 | Regulatory biostat reviewer | Needs independent external validation package and locked release process before immediate primary adoption. | **No (not yet)** |
| 8 | Sparse-event specialist | Appreciates GLMM lane and rare-event handling; asks for fuller GLMM variant coverage and stress tests. | **Pilot first** |
| 9 | Publication-bias specialist | Very positive on Egger/Begg/Peters/trim-fill/PET-PEESE/TES depth in one UI. | **Yes** |
| 10 | Reproducibility/open-science lead | Wants deterministic run manifests, version pinning, and one-click reproducible bundle exports. | **Pilot first** |
| 11 | Consultant meta-analyst (high throughput) | Immediate productivity gain over fragmented toolchains. | **Yes** |
| 12 | Clinician investigator (non-coder) | Immediate usability win; can execute advanced analyses without R/Stata scripting. | **Yes** |

## Adoption count
- **Immediate adoption: 7 / 12**
- **Pilot-first adoption: 4 / 12**
- **Not immediate: 1 / 12**

## What would raise immediate adoption to 10+/12
1. External oracle validation expansion for `DL2`, `CA`, `BMM`, `QG` across larger reference datasets.
2. Broader GLMM option parity and explicit method equivalence tests vs `metafor` model variants.
3. Release-grade reproducibility pack: run manifest, build hash, method citations, and audit exports by default.
4. Locked validation report template for journal/regulatory submission.

## Bottom line
This build is strong enough that most expert personas would adopt immediately for real analytical work, but full consensus immediate adoption is mainly blocked by external validation breadth and final GLMM parity depth.
